Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences, in the areas of, but not limited to, cancer biology, clinical cancer research, and cancer prevention.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to subscription journals offering OnlineOpen and Wiley fully Gold Open Access journals, as well as 240 Hindawi fully open access journals.
Agreement currently applies to both funded and unfunded papers but may be restricted to papers funded by the following organisations later in the year: UKRI; The Wellcome Trust; Cancer Research UK (CRUK); British Heart Foundation (BHF); Arthritis Research UK; Bloodwise; Parkinson’s UK
Responsible corresponding author* must be affiliated with The University of Manchester
There is a UK-wide limit on the total number of papers which can be published Open Access via this deal. Once this threshold is hit, the deal will pause, and immediate Open Access with Wiley will be unavailable for Manchester authors for a period of time. The Library will communicate any such changes to researchers when the limit is reached
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences.
*Wiley's agreement information advises: “The responsible corresponding author is the author who manages the manuscript and correspondence during the publication process - from submission through publication. This author has the authority to act on behalf of all the co-authors and will also be the contact for inquiries after publication”
Once your article is accepted, register or log-in to Wiley Author Services at www.wileyauthors.com
On your Author Dashboard in Author Services, click ‘Manage Article’ and select open access at no additional charge
Confirm the corresponding author(s) and responsible corresponding author – this person should be affiliated to UoM
Enter your funding information and confirm your UoM affiliation
Submit request for approval by clicking ‘Yes, make my article open access’
If you have a choice of Creative Commons license, the University encourages authors to select the Creative Commons Attribution (CC-BY) license. This may also be required by your funder.
During submission, identify UoM as your primary affiliation, and when asked how you will pay the OA charge, select ‘My institution has an agreement with Wiley’.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Cancer Nexus is an open-access, peer-reviewed, international journal that publishes high-quality, innovative research in the field of cancer research from clinicians, biomedical scientists, and bioinformatics engineers around the world. The journal focuses on the cutting-edge diagnosis and treatment and mechanism research in the clinical, basic and translational directions of oncology, and focuses on the cross-application of artificial intelligence in cancer clinical and basic research, aiming to establish a bridge of communication between clinical, laboratory and artificial intelligence. The journal is also interested in novel anti-tumor drugs, especially the rational design, screening and efficacy evaluation of AI-assisted anti-tumor drugs.
Cancer Nexus publishes Original Articles, Viewpoint, Case report, Review and Editorial. The journal will consider manuscripts in various fields of cancer and specific areas of interest, including but not limited to clinical trials of novel anti-cancer therapies, clinical epidemiology of cancer based on big data, AI-assisted translational cancer research, minimally invasive and non-invasive integrated diagnosis and treatment technology, cancer bioinformatics, cancer immunology and tumor vaccine development, tumor gene therapy, tumor targeted therapy, cancer omics research, mechanism research on tumor development, development and metastasis.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to subscription journals offering OnlineOpen and Wiley fully Gold Open Access journals, as well as 240 Hindawi fully open access journals.
Agreement currently applies to both funded and unfunded papers but may be restricted to papers funded by the following organisations later in the year: UKRI; The Wellcome Trust; Cancer Research UK (CRUK); British Heart Foundation (BHF); Arthritis Research UK; Bloodwise; Parkinson’s UK
Responsible corresponding author* must be affiliated with The University of Manchester
There is a UK-wide limit on the total number of papers which can be published Open Access via this deal. Once this threshold is hit, the deal will pause, and immediate Open Access with Wiley will be unavailable for Manchester authors for a period of time. The Library will communicate any such changes to researchers when the limit is reached
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences.
*Wiley's agreement information advises: “The responsible corresponding author is the author who manages the manuscript and correspondence during the publication process - from submission through publication. This author has the authority to act on behalf of all the co-authors and will also be the contact for inquiries after publication”
Once your article is accepted, register or log-in to Wiley Author Services at www.wileyauthors.com
On your Author Dashboard in Author Services, click ‘Manage Article’ and select open access at no additional charge
Confirm the corresponding author(s) and responsible corresponding author – this person should be affiliated to UoM
Enter your funding information and confirm your UoM affiliation
Submit request for approval by clicking ‘Yes, make my article open access’
If you have a choice of Creative Commons license, the University encourages authors to select the Creative Commons Attribution (CC-BY) license. This may also be required by your funder.
During submission, identify UoM as your primary affiliation, and when asked how you will pay the OA charge, select ‘My institution has an agreement with Wiley’.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer. Subject categories include:
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to subscription journals offering OnlineOpen and Wiley fully Gold Open Access journals, as well as 240 Hindawi fully open access journals.
Agreement currently applies to both funded and unfunded papers but may be restricted to papers funded by the following organisations later in the year: UKRI; The Wellcome Trust; Cancer Research UK (CRUK); British Heart Foundation (BHF); Arthritis Research UK; Bloodwise; Parkinson’s UK
Responsible corresponding author* must be affiliated with The University of Manchester
There is a UK-wide limit on the total number of papers which can be published Open Access via this deal. Once this threshold is hit, the deal will pause, and immediate Open Access with Wiley will be unavailable for Manchester authors for a period of time. The Library will communicate any such changes to researchers when the limit is reached
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences.
*Wiley's agreement information advises: “The responsible corresponding author is the author who manages the manuscript and correspondence during the publication process - from submission through publication. This author has the authority to act on behalf of all the co-authors and will also be the contact for inquiries after publication”
Once your article is accepted, register or log-in to Wiley Author Services at www.wileyauthors.com
On your Author Dashboard in Author Services, click ‘Manage Article’ and select open access at no additional charge
Confirm the corresponding author(s) and responsible corresponding author – this person should be affiliated to UoM
Enter your funding information and confirm your UoM affiliation
Submit request for approval by clicking ‘Yes, make my article open access’
If you have a choice of Creative Commons license, the University encourages authors to select the Creative Commons Attribution (CC-BY) license. This may also be required by your funder.
During submission, identify UoM as your primary affiliation, and when asked how you will pay the OA charge, select ‘My institution has an agreement with Wiley’.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to subscription journals offering OnlineOpen and Wiley fully Gold Open Access journals, as well as 240 Hindawi fully open access journals.
Agreement currently applies to both funded and unfunded papers but may be restricted to papers funded by the following organisations later in the year: UKRI; The Wellcome Trust; Cancer Research UK (CRUK); British Heart Foundation (BHF); Arthritis Research UK; Bloodwise; Parkinson’s UK
Responsible corresponding author* must be affiliated with The University of Manchester
There is a UK-wide limit on the total number of papers which can be published Open Access via this deal. Once this threshold is hit, the deal will pause, and immediate Open Access with Wiley will be unavailable for Manchester authors for a period of time. The Library will communicate any such changes to researchers when the limit is reached
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences.
*Wiley's agreement information advises: “The responsible corresponding author is the author who manages the manuscript and correspondence during the publication process - from submission through publication. This author has the authority to act on behalf of all the co-authors and will also be the contact for inquiries after publication”
Once your article is accepted, register or log-in to Wiley Author Services at www.wileyauthors.com
On your Author Dashboard in Author Services, click ‘Manage Article’ and select open access at no additional charge
Confirm the corresponding author(s) and responsible corresponding author – this person should be affiliated to UoM
Enter your funding information and confirm your UoM affiliation
Submit request for approval by clicking ‘Yes, make my article open access’
If you have a choice of Creative Commons license, the University encourages authors to select the Creative Commons Attribution (CC-BY) license. This may also be required by your funder.
During submission, identify UoM as your primary affiliation, and when asked how you will pay the OA charge, select ‘My institution has an agreement with Wiley’.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Cardiology Research and Practice is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of cardiology.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
publishes case reports and case series in all areas of dentistry, including periodontal diseases, dental implants, oral pathology, as well as oral and maxillofacial surgery.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
